1 Followers USX:SUPN - Supernus Pharmaceuticals Inc Supernus Pharmaceuticals Inc
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance
Quarterly TTM
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 408.9M
35.3%
392.75M
-3.9%
520.4M
32.5%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 15.36M
0.9%
16.66M
8.5%
52.46M
214.9%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 393.54M
37.1%
376.1M
-4.4%
467.94M
24.4%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 264.45M
30.5%
244.18M
-7.7%
344.8M
41.2%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 249.1M
32.9%
227.52M
-8.7%
292.34M
28.5%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 144.44M
45.1%
148.57M
2.9%
175.6M
18.2%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 110.99M
93.8%
113.06M
1.9%
126.95M
12.3%
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 110.99M
93.8%
113.06M
1.9%
126.95M
12.3%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 110.99M
93.7%
113.06M
1.9%
126.95M
12.3%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.13
88.5%
2.16
1.4%
2.41
11.6%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.05
89.8%
2.1
2.4%
2.36
12.4%
Values are in USD whenever applicable | Fiscal year ends on December 31
Powered by Morningstar